AUM$139.0M
Expense Ratio0.50%
NAV$51.95
Holdings103
InceptionDec 30, 2014
Price Chart
Key Statistics
Previous Close
$51.70Day Range
$49.72$51.01
52-Week Range
$23.59$54.18
Avg Volume
21.7KDividend Yield
2.29%Expense Ratio
0.50%AUM
$139.0MShares Outstanding
2.7MSector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 83.67% |
| Netherlands | 3.36% |
| Canada | 3.14% |
| Ireland | 3.04% |
| Switzerland | 1.86% |
| Belgium | 1.40% |
| China | 1.39% |
| United Kingdom | 1.27% |
| Germany | 0.87% |
Fund Information
- Issuer
- ALPS Funds
- Category
- Healthcare
- Subcategory
- Healthcare
- Inception Date
- Dec 30, 2014
- Exchange
- NYSE_ARCA
- Description
- The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).
Similar ETFs
The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund issued by ALPS Funds that launched on Dec 30, 2014. It currently manages $139.0M in assets under management. The fund charges an expense ratio of 0.50%. The fund holds 103 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 30.4% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | KYMR | Kymera Therapeutics Inc. | 4.28% | 70,365 | $6.0M |
| 2 | CELC | Celcuity Inc. | 3.48% | 41,241 | $4.8M |
| 3 | CGON | CG oncology Inc. | 3.25% | 71,897 | $4.5M |
| 4 | XENE | Xenon Pharmaceuticals Inc. | 3.00% | 68,873 | $4.2M |
| 5 | MIRM | Mirum Pharmaceuticals Inc. | 3.00% | 45,804 | $4.2M |
| 6 | ALKS | Alkermes PLC | 2.94% | 147,168 | $4.1M |
| 7 | FOLD | Amicus Therapeutics Inc. | 2.84% | 274,988 | $3.9M |
| 8 | APGE | Apogee Therapeutics Inc. | 2.65% | 48,872 | $3.7M |
| 9 | VKTX | Viking Therapeutics Inc. | 2.51% | 100,746 | $3.5M |
| 10 | ACAD | ACADIA Pharmaceuticals Inc. | 2.45% | 150,789 | $3.4M |
| 11 | DNTH | Dianthus Therapeutics Inc. | 2.39% | 38,214 | $3.3M |
| 12 | NAMS | Newamsterdam Pharma Co. NV | 2.27% | 101,063 | $3.2M |
| 13 | CRNX | Crinetics Pharmaceuticals Inc. | 2.27% | 84,576 | $3.2M |
| 14 | GPCR | Structure Therapeutics Inc. | 2.27% | 54,083 | $3.1M |
| 15 | SYRE | Spyre Therapeutics Inc. | 2.07% | 69,157 | $2.9M |
Page 1 of 3
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | -2.67% | — | ||
| 1W | +2.29% | — | ||
| 1M | +0.91% | — | ||
| 3M | +1.23% | — | ||
| 6M | +45.37% | — | ||
| YTD | +3.43% | — | ||
| 1Y | +67.52% | — | ||
| 3Y | +85.22% | — | ||
| 5Y | -5.10% | — |
Moving Averages
20-Day MA
N/A
50-Day MA
N/A
200-Day MA
N/A
Price with Moving Averages
Support & Resistance
52-Week High
$54.18
Current Price
$50.32
52-Week Low
$23.59
$23.59$54.18
Current Yield
2.29%
Annual Dividend
$2.0445
Frequency
1x/year
Last Ex-Date
Dec 19, 2024
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 19, 2024 | $1.1735 | Dec 26, 2024 |
| Dec 21, 2023 | $0.0711 | Dec 27, 2023 |
| Dec 19, 2019 | $0.0158 | Dec 27, 2019 |
| Dec 20, 2018 | $0.7841 | Dec 27, 2018 |
| Dec 21, 2017 | $0.5795 | Dec 28, 2017 |
Dividend Payments Over Time
Category Comparison
| Metric | SBIO | Healthcare(223 ETFs) | Healthcare(44 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.50% | 0.60% | 0.59% |
| AUM | $139.0M | $1.25B | $881.1M |
| Dividend Yield | 2.29% | 2.75% | 2.35% |
| Avg Volume | 21.7K | 769.9K | 99.5K |
| Holdings | 103 | 182 | 134 |
| Performance | |||
| 1-Month Return | — | -3.02% | -2.09% |
| 6-Month Return | — | +5.85% | +3.03% |
| YTD Return | — | +0.17% | -1.90% |
| 1-Year Return | — | +16.65% | +12.17% |
Compare with Another ETF
Search for an ETF to compare with SBIO: